BioTech
-
Raw milk, Wegovy tests, Eisai and Biogen
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your…
Read More » -
Opinion | What MAGA’s Beef With Lab-Grown Meat Says About the G.O.P.
Governor Ron DeSantis of Florida recently signed a bill that bans both the production and the sale of lab-grown meat.…
Read More » -
Novavax stock, FogPharma, Novo Nordisk
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your…
Read More » -
Element Biosciences CEO lays out genome sequencing strategy
SAN DIEGO — Companies racing to read the genome accurately, quickly, and affordably have hit a snag recently, with several…
Read More » -
Late-stage results set up Cytokinetics heart drug to compete with Bristol
Late-stage results of Cytokinetics’ drug for a rare heart disease suggest it can compete with a similar treatment sold by…
Read More » -
Maze, AC Immune, Merck, OnKure
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your…
Read More » -
STAT+: Can AI build custom ‘n-of-1’ drugs faster? Maybe not yet, new case study suggests
Two years ago, Yiwei Shi was searching desperately for someone to build a drug for her newborn son, Leo. Leo…
Read More » -
Trial using CRISPR to edit HIV out of cells disappoints
BALTIMORE — An ambitious effort to cure HIV with CRISPR genome editing fell short in an early clinical trial, investigators…
Read More » -
Sanofi, Novavax, Maze x Shionogi news
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your…
Read More » -
Shionogi licenses Pompe disease therapy from Maze Therapeutics
After seeing its last deal go bust in the face of regulatory scrutiny, Maze Therapeutics has found another suitor for…
Read More »